Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

NCT01579903 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: moroctocog alfa (AF-CC)
DRUG: moroctocog alfa (AF-CC)

Sponsor

Pfizer